Tru-D SmartUVC Robot Gives Patient Peace of Mind

MEMPHIS, Tenn., Feb. 24, 2016 /PRNewswire/ -- The value and benefits of Tru-D SmartUVC are quickly becoming widely known beyond hospital staff and medical professionals. The demand for Tru-D is now being heard from patients and their families, who want to ensure they receive the highest level of care possible.

Logo - http://photos.prnewswire.com/prnh/20160223/336670LOGO

Photo - http://photos.prnewswire.com/prnh/20160223/336669

With his wife's history of infections and a complicated surgery looming, Jack Gunter wanted to make sure her medical team took every measure available to reduce the chance of any post-surgery complications or infections. After learning about Tru-D, Gunter inquired about utilizing the UV technology in the operating room prior to his wife's leg amputation. As a Tru-D hospital, the staff made arrangements for the germ-eliminating robot to disinfect the room prior to the procedure. Gunter says his wife is now well on her way to recovery and is successfully using a prosthetic leg after her above-the-knee amputation.

"Having Tru-D was great for our mental framework," said Gunter. "My wife's two prior, major surgeries resulted in two different bacteria in her leg which was the reason for the amputation.  We will never know what caused those infections, but knowing Tru-D was going to be used helped us feel everything was being done to make sure she did not have an infection with the amputation."

Once a hospital staff member cleans a room using traditional cleaning methods, Tru-D is brought in to complete the process. Its patented Sensor360 technology analyzes the space, including shape, size and contents, to determine the proper UV dose to be administered. Spending the minimum time necessary to successfully eliminate infectious germs from all room surfaces, including shadowed areas, Tru-D alerts the operator when the disinfection process is complete.

"As more patients learn about Tru-D and its benefits in reducing hospital-acquired infections, we hope the demand urges more hospitals to invest in added patient quality and care," said Chuck Dunn, president and CEO of Tru-D SmartUVC.

Tru-D has been clinically validated by more than a dozen third-party studies including the recent Benefits of Enhanced Terminal Room Disinfection (BETR-D) study funded by the Centers for Disease Control. The only UV device selected for the study due to its unique technology and ability to eliminate human error, the study proved that enhanced terminal room disinfection methods, especially when Tru-D was added to the standard cleaning strategy, decreased the cumulative incidence of multidrug-resistant organisms by up to 30 percent.

For more information, visit Tru-D.com

About Tru-D SmartUVC
Tru-D SmartUVC is the only UV disinfection device backed by a CDC-funded, randomized clinical trial to show that it is capable of reducing the transmission of health care-associated infections by up to 30 percent.  More Tru-Ds have been deployed to disinfect hospitals across the globe than all other competing look-alike offerings, fighting deadly pathogens such as C. diff, MRSA, CRE, VRE, MERS, Ebola and many more. An effective and innovative technology backed by sound science, Tru-D SmartUVC is on a mission to eradicate HAIs making hospitals safer places for patients and staff. For information and links to independent studies on Tru-D, visit Tru-D.com.

Media Contact:
Christin Yates
Tru-D Public Relations
901-774-5771
Email

SOURCE Tru-D SmartUVC